Skip to main content
Premium Trial:

Request an Annual Quote

SpectronRx Coronavirus Test Gets FDA Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization for SpectronRx's Hymon SARS-CoV-2 Test Kit.

According to the Indianapolis-based company, the test kit is designed to detect regions of the virus' nucleocapsid and envelope genes in upper respiratory specimens and bronchoalveolar lavage. It runs on Thermo Fisher Scientific's Applied Biosystems 7500 RT-PCR system.

Use of the test is limited to laboratories CLIA-certified to perform high-complexity tests, the FDA said.

The kit is manufactured by Suzhou, China-based HymonBio.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.